Combination: Ibupramol — Ibuprofen IP 200 mg + Paracetamol IP 325 mg per uncoated tablet.
Other variants: Ibuprofen IP / BP tablets 200 mg, 400 mg and 600 mg (see specifications).
Usage: Pain relief; ibuprofen also reduces inflammation and fever.
Category: Anti Analgesic Painkiller Drugs
Therapeutic Category: NSAID, Analgesic, Antipyretic, Anti-inflammatory
SKU: Ibuprofen & Paracetamol Tablets
Categories: Contract Manufacturer, Formulations Exporter India, Manufacturing Pharmaceutical Company India, Pharmaceutical Exporter India, Pharmaceutical Formulations India, Tablets Manufacturer, WHO GMP Certified Formulations
Ibuprofen & Paracetamol Tablets is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.
For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.
Healthy Life Pharma Pvt. Ltd. presents Ibuprofen tablets and the Ibupramol fixed-dose combination of ibuprofen with paracetamol. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce pain, inflammation and fever; paracetamol is an analgesic and antipyretic. The supplied combination composition is Ibuprofen IP 200 mg + Paracetamol IP 325 mg per uncoated tablet.
Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)
| Product / Brand | Strength | Composition per tablet | Dosage form |
|---|---|---|---|
| Ibuprofen Tablets IP | 200 mg | Ibuprofen IP 200 mg | Sugar-coated |
| Ibuprofen Tablets IP | 400 mg | Ibuprofen IP 400 mg | Sugar-coated |
| Ibupramol | 200 mg + 325 mg | Ibuprofen IP 200 mg + Paracetamol IP 325 mg | Uncoated |
| Ibuprofen Tablets IP | 400 mg | Ibuprofen IP 400 mg | Film-coated |
| Makupar-200 (BP) | 200 mg | Ibuprofen BP 200 mg | Sugar-coated |
| Makupar-400 (BP) | 400 mg | Ibuprofen BP 400 mg | Sugar-coated |
| Ibu-600 (BP) | 600 mg | Ibuprofen BP 600 mg | Film-coated |
| Ibuprofen Tablets BP | 400 mg | Ibuprofen BP 400 mg | Film-coated; erythrosine and excipients noted |
Therapeutic class: NSAID, analgesic, antipyretic and anti-inflammatory. CAS: Ibuprofen 15687-27-1; Paracetamol 103-90-2. Important: The supplied combination is 200 mg + 325 mg, not 400 mg + 325 mg as stated in the background description. Shelf life, pack formats and regulatory standards must be confirmed for each SKU.
Ibuprofen and paracetamol have distinct powder-handling and compression properties. Formulation development may require appropriate granulation, excipients, moisture control, and validated compression and coating processes. The confirmed Ibupramol product is uncoated; individual ibuprofen tablets have the sugar-coated and film-coated presentations shown above. Specific manufacturing equipment and processes should be confirmed against the product dossier.
Product-specific quality control may include identity, assay of each active ingredient, content uniformity, disintegration or dissolution, related substances, microbial limits where applicable, and stability. Test limits must follow the approved IP/BP specification and batch release documents; no unverified numeric limits are claimed here.
Ibuprofen: inhibits cyclo-oxygenase enzymes and prostaglandin synthesis, reducing inflammation, pain and fever. Paracetamol: relieves pain and fever through mechanisms that are not completely understood. The combination may provide additional short-term analgesia in appropriate patients; it is not automatically suitable for all pain or fever conditions.
Possible uses, subject to local product approval and medical advice, include dental pain, musculoskeletal pain and other short-term painful conditions. Avoid implying the combination is always superior or suitable for severe pain without clinical evaluation.
For B2B enquiries, request product-specific certificates of analysis, stability data, applicable manufacturing certificates, and CTD/ACTD registration documents where available. Export registration, packaging options and market authorizations depend on the destination country and individual formulation.
Q: Which ibuprofen–paracetamol combination is confirmed?
A: Ibupramol, an uncoated tablet containing Ibuprofen IP 200 mg and Paracetamol IP 325 mg.
Q: Is 400 mg + 325 mg available?
A: That strength appears in the supplied narrative but no matching composition was provided; availability requires confirmation.
Q: Can this be taken with other painkillers?
A: Do not combine it with additional paracetamol products or other NSAIDs without professional advice because of overdose and adverse-effect risks.
Q: Should it be taken with food?
A: Food may reduce stomach irritation from ibuprofen, although it does not eliminate the risk of gastrointestinal bleeding.
Follow the approved product label and a clinician’s instructions. Dose and duration depend on age, indication, medical history and the exact strength. Use the lowest effective NSAID dose for the shortest necessary time. The supplied narrative’s fixed regimen is not adopted as a universal instruction because it does not match the confirmed combination strength.
Store in the original packaging, protected from excess heat, light and moisture, in accordance with the approved label. Keep out of reach of children.